HLA

Aims & Scope

HLA publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity.

The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, KIR, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules.

Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or haematopoietic stem cell transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.1
2024	5.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.214

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	108

Journal Rank

Year	Value
2024	20398

Journal Citation Indicator

Year	Value
2024	509

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• 25 years of the IPD‐IMGT/HLA <scp>D</scp>atabase

  Citation: 200

  Authors: James, Dominic J., Steven G. E.

• Tumor‐associated antigens: Tn antigen, <scp>sTn</scp> antigen, and T antigen

  Citation: 178

  Authors: C., H., Y., H., Y., Y., H.

• Distribution of <scp>HLA</scp> allele frequencies in 82 Chinese individuals with coronavirus disease‐2019 (COVID‐19)

  Citation: 167

  Authors: Wei, Wei, Jingjing, Ji, Faming

• Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0

  Citation: 147

  Authors: Carolyn K., Jane, Kim, Jürgen, Jan A., Daniel, Alexander H., Pablo, Maria B. R., Malgorzata, Lucie, Pavel, Betina S., Latha, Ankit, Tiina, Tigran, Rafi, Anastasios, John, Nezih, Sigal, Nira, Nicoletta, Reem, Raewyn, Heather, Irene, Ahmed, Mohsen, Ali, Dunia, Grazia, Pawinee, Louise, Ashminder, Mats, Jason

• <scp>HLA</scp> allele frequencies and susceptibility to <scp>COVID</scp>‐19 in a group of 99 Italian patients

  Citation: 139

  Authors: Antonio, Marco, Michela, Laura, Chiara, Vito Luigi, Paola, Francesca, Andrea, Rita, Massimo, Sergio, Giuseppe, Franco

• Evaluation of the AllType kit for HLA typing using the Ion Torrent S5 XL platform

  Citation: 139

  Authors: Marine, Mamy, Laura, Isabelle, Vincent, Marco, Gwendaline, Jonathan

• The influence of HLA genotype on the severity of COVID‐19 infection

  Citation: 112

  Authors: David J., Stephen C., Benedicte A., Gabrielle, Shonali, Rebecca, John, Carlos

• HLA common and well‐documented alleles in China

  Citation: 97

  Authors: Y., J., W., D., M., X., B., C., J., Z., Z., W., Q., W., P., R., G., G., B., L., G., Y., Z., Y., Y., W., X., X., J., J., Q., Y., J., J., Z., F., D.

• <scp>NovAT</scp> tool—Reliable novel <scp>HLA</scp> alleles identification from next‐generation sequencing data

  Citation: 96

  Authors: Tamara, Arina, Kristina, Anna, Maria, Igor

• Binding affinities of 438 <scp>HLA</scp> proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest <scp>HLA</scp> peptide binders in populations worldwide

  Citation: 88

  Authors: Rodrigo, Evelyn, Da, Stéphane, João, Bastien, José M., Alicia

---